Early palliative care in metastatic uveal melanoma (early together): protocol of a prospective randomized Phase III trial.
AuteursPiperno-Neumann S, Koning L, Marchal T, Gastaud L, Waechter L, Fogliarini A, Bouleuc C, Libert Y, Seban R, Thery L, Ducoulombier A, Rodrigues M, Bredart A, Savignoni A, Dolbeault S, Burnod A
Survival outcomes for patients with invasive lobular cancer by MammaPrint: Results from the MINDACT phase III trial.
AuteursMetzger Filho O, Cardoso F, Poncet C, Desmedt C, Linn S, Wesseling J, Hilbers F, Delaloge S, Pierga JY, Brain E, Vrijaldenhoven S, Neijenhuis PA, Rutgers EJT, Piccart M, van 't Veer LJ, Viale G
A transcriptomic score to classify the inflammation-dysplasia-cancer sequence lesions in Inflammatory Bowel Disease.
AuteursCremer A, Rosewick N, Kelsey M, Trépo E, Libert F, De Vos M, Baert F, Moreels T, Louis E, Rahier JF, Demetter P, Sedivy JM, Vermeire S, Franchimont D
Morphology of Retinal Hemangioblastoma in von Hippel-Lindau Disease Revealed by Optical Coherence Tomography Angiography.
AuteursLaich Y, Lang SJ, Glatz A, Farassat N, Bucher F, Nuessle S, Böhringer D, Lagrèze WA, Sideris S, Maloca P, Lange C, Reinhard T, Agostini H, Reich M
Prognostic implications of risk definitions from the monarchE and NATALEE trials.
AuteursArecco L, Blondeaux E, Bruzzone M, Arpino G, De Angelis C, De Laurentiis M, Caputo R, Fabi A, Sanna V, Gori S, Puglisi F, Boni L, Nardin S, Giannubilo I, Perachino M, Borea R, Agostinetto E, de Azambuja E, Lambertini M, Del Mastro L